Valuation Becton, Dickinson and Company London S.E.

Stocks

Market Closed - London S.E. 09:30:01 2026-09-09 EDT			5-day change	1st Jan Change
177.15 ^USD	-1.59%		-5.24%	-9.45%

09-09	Becton, Dickinson and Company Presents at Wells Fargo 21st Annual Healthcare Conference, Sep-08-2026 through Sep-10-2026
09-01	Medtronic Raises Full-Year Outlook Following Fiscal First-Quarter Beat	MT

Data adjusted to current consolidation scope

Fiscal Period: September	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	70,597	63,550	75,002	69,688	53,648	48,054	-	-
Change	-	-9.98%	18.02%	-7.08%	-23.02%	-10.43%	-	-
Enterprise Value (EV) ¹	85,924	78,609	89,465	88,081	72,188	63,939	62,006	60,240
Change	-	-8.51%	13.81%	-1.55%	-18.04%	-11.43%	-3.02%	-2.85%
P/E	35.9x	37.9x	52.3x	40.7x	32.2x	34x	19x	15.6x
PBR	2.95x	3.21x	3.71x	2.69x	2.1x	1.88x	1.77x	1.68x
PEG	-	-2.7x	-3.3x	2x	-17.36x	-3.1x	0.2x	0.7x
Capitalization / Revenue	3.49x	3.37x	3.87x	3.44x	2.46x	2.49x	2.44x	2.34x
EV / Revenue	4.24x	4.17x	4.62x	4.35x	3.31x	3.32x	3.15x	2.93x
EV / EBITDA	14.7x	15.2x	13.1x	12.4x	12x	11.4x	10.8x	9.9x
EV / EBIT	17.3x	18x	19.6x	18.3x	13.2x	13.2x	12.6x	11.6x
EV / FCF	25.2x	52.5x	42.3x	28.2x	27x	20.2x	23.3x	21.5x
FCF Yield	3.98%	1.91%	2.37%	3.54%	3.7%	4.94%	4.29%	4.65%
Dividend per Share ²	3.32	3.48	3.64	3.8	4.16	3.924	3.991	3.993
Rate of return	1.35%	1.56%	1.41%	1.58%	2.22%	2.22%	2.26%	2.26%
EPS ²	6.85	5.88	4.94	5.93	5.82	5.189	9.309	11.28
Distribution rate	48.5%	59.2%	73.7%	64.1%	71.5%	75.6%	42.9%	35.4%
Net sales ¹	20,248	18,870	19,372	20,245	21,840	19,260	19,689	20,530
EBITDA ¹	5,838	5,160	6,846	7,099	6,028	5,628	5,759	6,087
EBIT ¹	4,971	4,362	4,558	4,813	5,468	4,832	4,928	5,178
Net income ¹	2,002	1,689	1,424	1,726	1,678	1,437	2,340	2,714
Net Debt ¹	15,327	15,059	14,463	18,393	18,540	15,885	13,952	12,185
Reference price ²	245.82	222.83	258.53	241.10	187.17	176.42	176.42	176.42
Nbr of stocks (in thousands)	287,190	285,195	290,109	289,042	286,627	272,387	-	-
Announcement Date	11/4/21	11/10/22	11/9/23	11/7/24	11/6/25	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ABBOTT LABORATORIES	30.19x	4.1x	15.74x	2.44%	182B
MEDTRONIC PLC	19.44x	3.55x	12.69x	3.09%	118B
CENCORA, INC.	17.7x	0.21x	12.92x	0.74%	61.7B
HOYA CORPORATION	28.46x	7x	18.03x	1.4%	50.55B
BECTON, DICKINSON AND COMPANY	34.65x	3.36x	11.52x	2.18%	48.98B
DEXCOM, INC.	33.62x	5.91x	18.54x	-.--%	31.65B
MEDLINE INC.	43.96x	1.28x	11.86x	0.21%	29.87B
WEST PHARMACEUTICAL SERVICES, INC.	39.29x	6.88x	24.67x	0.27%	23.71B
TERUMO CORPORATION	16.9x	2.69x	9.55x	1.64%	21.78B
Average	29.36x	3.89x	15.06x	1.33%	63.1B
Weighted average by Cap.	27.62x	3.77x	14.73x	1.9%